GANESH TAMANG: Open Payments
NPI 1225748197 · ESSEX, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 52 payments from 17 companies in 2025. Trend: 2023 $1,092 · 2024 $918 · 2025 $894
Food & beverage: $894
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $216 |
| AstraZeneca Pharmaceuticals LP | 7 | $173 |
| GlaxoSmithKline, LLC. | 5 | $103 |
| PFIZER INC. | 3 | $81 |
| Novo Nordisk Inc | 3 | $54 |
| Lilly USA, LLC | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Hologic Sales and Service, LLC | 1 | $22 |
| Dexcom, Inc. | 1 | $22 |
Products named: VRAYLAR, BREZTRI, TRELEGY ELLIPTA, JARDIANCE, AIRSUPRA, Ozempic, CAPLYTA, VYNDAQEL.
Industry payments across MD — which companies pay providers there.
